Welcome to Open Journal of Pharmaceutical Science and Research

Full text coming soon

References

1. Friede T, Kieser M. 2006. Sample size recalculation in internal pilot study designs: a review. Biometrical Journal. 48: 537-555. [Ref.]
2. Proschan MA. 2009. Sample size re-estimation in clinical trials. Biometrical Journal. 51: 348-357. [Ref.]
3. Menon S, Massaro J, Pencina MJ, et al. 2013. Comparison of operating characteristics of commonly used sample size re-estimation procedures in a two-stage design. Communications in Statistics-Simulation and Computation. 42: 1140-1152. [Ref.]
4. Pritchett YL, Menon S, Marchenko O, et al. 2015. Sample size re-estimation designs in confirmatory clinical trials-current state, statistical considerations, and practical guidance. Statistics in Biopharmaceutical Research. 7: 309-321. [Ref.]
5. Guidance Draft. 2018. Adaptive Designs for Clinical Trials of Drugs and Biologics. Center for Biologics Evaluation and Research (CBER). [Ref.]
6. Gould LA, Shih WJ. 1992. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Communications in Statistics-Theory and Methods. 21: 2833-2853. [Ref.]
7. Gould LA. 1997. Issues in blinded sample size re-estimation. Communications in Statistics-Simulation and Computation. 26: 1229-1239. [Ref.]
8. Friede T, Kieser M. 2002. On the inappropriateness of an EM algorithm based procedure for blinded sample size re-estimation. Statistics in Medicine. 21: 65-176. [Ref.]
9. Zucker DM, Wittes JT, Schabenberger O, et al. 1999. Internal pilot studies II: comparison of various procedures. Statistics in Medicine. 18: 3493-3509. [Ref.]
10. Kieser M, Friede T. 2003. Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Statistics in Medicine. 22: 3571-3581. [Ref.]
11. Stein C. 1945. A two-sample test for a linear hypothesis whose power is independent of the variance. The Annals of Mathematical Statistics. 16: 243-258. [Ref.]
12. Wittes J, Brittain E. 1990. The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine. 9: 65-72. [Ref.]
13. Kieser M, Friede T. 2000. Re-calculating the sample size in internal pilot study designs with control of the type I error rate. Statistics in Medicine. 19: 901-911. [Ref.]
14. Friede T, Kieser M. 2001. Sample size adjustment in clinical trials for proving equivalence. Drug information journal. 35: 1401-1408. [Ref.]
15. Bauer P, Kohne K. 1994. Evaluation of experiments with adaptive interim analyses. Biometrics. 1029-1041. [Ref.]
16. Cui L, Hung HM, Wang SJ. 1999. Modification of sample size in group sequential clinical trials. Biometrics. 55: 853-857. [Ref.]
17. Lehmacher W, Wassmer G. 1999. Adaptive sample size calculations in group sequential trials. Biometrics. 55: 1286-1290. [Ref.]
18. Mehta C, Liu L. 2016. An objective re-evaluation of adaptive sample size re?estimation: commentary on ‘Twenty-five years of confirmatory adaptive designs’. Statistics in Medicine. 35: 350-358. [Ref.]
19. Proschan MA, Hunsberge SA. 1995. Designed extension of studies based on conditional power. Biometrics. 1315-1324. [Ref.]
20. Müller HH, Schäfer H. 2001. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics, 57: 886-891. [Ref.]
21. Denne JS. 2001. Sample size recalculation using conditional power. Statistics in medicine. 20: 2645-2660. [Ref.]
22. Gaffney M, Ware JH. 2017. An evaluation of increasing sample size based on conditional power. Journal of Biopharmaceutical Statistics. 1-11. [Ref.]
23. Tsiatis AA, Mehta C. 2003. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika. 90: 367-378. [Ref.]
24. Chen YH, DeMets DL, Gordon Lan KK. 2004. Increasing the sample size when the unblinded interim result is promising. Statistics in Medicine. 23: 1023-1038. [Ref.]
25. Gao P, Ware JH, Mehta C. 2008. Sample size re-estimation for adaptive sequential design in clinical trials. Journal of Biopharmaceutical Statistics. 18: 1184-1196. [Ref.]
26. Mehta CR, Pocock SJ. 2011. Adaptive increase in sample size when interim results are promising: a practical guide with examples. Statistics in Medicine. 30: 3267-3284. [Ref.]
27. Jennison C, Turnbull BW. 2015. Adaptive sample size modification in clinical trials: start small then ask for more?. Statistics in medicine. 34: 3793-3810. [Ref.]
28. Hsiao ST, Liu L, Mehta CR. 2018. Optimal promising zone designs. Biometrical Journal. [Ref.]
29. Emerson SS, Levin GP, Emerson SC. 2011. Comments on ‘Adaptive increase in sample size when interim results are promising: A practical guide with examples’. Statistics in Medicine, 30: 3285-3301. [Ref.]
30. Bauer P, Koenig F. 2006. The reassessment of trial perspectives from interim data—a critical view. Statistics in medicine. 25: 23-36. [Ref.]
31. Shih WJ, Li G, Wang Y. 2016. Methods for flexible sample-size design in clinical trials: Likelihood, weighted, dual test, and promising zone approaches. Contemporary Clinical Trials. 47: 40-48. [Ref.]
32. Levin GP, Emerson SC, Emerson SS. 2013. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation. Statistics in Medicine, 32: 1259-1275. [Ref.]

Download Provisional PDF Here